Basic principles in oncology course
18.08.2025 - 21.09.2025
HYBRID EVENT
COURSES AND SEMINARS
Breast cancer, Gastro-intestinal tumours, Genito-urinary cancers, Lung cancer, Melanoma
Block 2
18.09.2025 - 21.09.2025
Basic Principles in Oncology Course
Programme
18 September | ||
| 18:00 | Arrivals and registration | |
19 September | ||
| 8:10 | Departure from hotel | |
| 8:45 | Registration | |
| 9:00 | Welcome and general introduction Alexandru Eniu, CH - Barbara Alicja Jereczek-Fossa, IT - Sophie Servais, LU | |
| 9:20 | Europe’s Beating Cancer Plan: state of play Matthias Schuppe , LU | |
| 9:35 | Principles of cancer etiology and epidemiology Freddie Bray, FR | |
| 10:05 | The hallmarks of cancer: Perspectives for cancer medicine Douglas Hanahan, CH | |
| 10:35 | Principles of cancer genetics Abdelkader Heddar, LU | |
| 11:05 | Coffee break | |
| 11:30 | Basic cancer pathology Carolin Mogler, DE | |
| 12:00 | Principles of biomarker assessment including role of NGS Carolin Mogler, DE | |
| 12:20 | Principles of staging systems Ian Tannock, CA | |
| 12:50 | Basic principles of imaging in cancer assesment Petra Steyerova, CZ | |
| 13:10 | Role of nuclear medicine Lioe-fee De Geus-oei, NL | |
| 13:30 | Lunch | |
| 14:30 | Principles of surgical oncology Riccardo A. Audisio, SE | |
| 15:00 | Principles of radiotherapy: Planning , techniques and side effects Barbara Alicja Jereczek-Fossa, IT | |
| 15:30 | How to prepare a clinical case presentation Silvia Brotea-Mosoiu, RO | |
| 15:45 | Coffee break | |
| 16:15 | Introduction to clinical trials Ian Tannock, CA | |
| 17:15 | Transfer to hotel | |
| 19:00 | Free evening to explore Luxembourg | |
20 September | ||
| 8:25 | Departure from hotel | |
| 9:00 | Basic principles of chemotherapy with toxicity Stefan Rauh, LU | |
| 9:30 | Basic principles of targeted therapy with toxicity Joseph Gligorov, FR | |
| 10:00 | Basic principles of endocrine therapy with toxicity Patrick Neven, BE | |
| 10:30 | Basic principles of immunotherapy with toxicity Danny Kupka, CH | |
| 11:00 | Coffee break | |
| 11:30 | Principles of patient assessment | |
| 12:00 | Clinical case presentations and discussion | |
| 12:00 | Pathology ( metastasis of unknown primary) Carolin Mogler, DE | |
| 12:20 | Immunotherapy Danny Kupka, CH | |
| 12:40 | Radiotherapy Barbara Alicja Jereczek-Fossa, IT | |
| 13:00 | Targeted therapy Patrick Neven, BE | |
| 13:30 | Lunch | |
| 14:30 | Oncological emergencies (including infections) Anastasia Constantinidou, CY | |
| 15:00 | Principles of communication with the cancer patients Luzia Travado, PT | |
| 15:30 | Multidisciplinary care and tumor boards Alexandru Eniu, CH | |
| 16:00 | Survivorship issues in cancer patients Luzia Travado, PT | |
| 16:30 | Coffee break | |
| 17:00 | Availability and rational use of anti-cancer therapies (priorities or access to drugs) Alexandru Eniu, CH | |
| 17:30 | Career planning and opportunities - Round table discussion Silvia Brotea-Mosoiu, RO - Alexandru Eniu, CH - Barbara Alicja Jereczek-Fossa, IT - Ian Tannock, CA | |
| 18:00 | Transfer to hotel | |
| 20:00 | Dinner at hotel | |
21 September | ||
| 8:25 | Departure from hotel | |
| 9:00 | Principles of supportive care in cancer patients Matti Aapro, CH | |
| 9:30 | Cancer in the Elderly Matti Aapro, CH | |
| 10:00 | Principles of palliative care in cancer patients Dirk Schrijvers, BE | |
| 10:30 | Coffee break | |
| 11:00 | Critical appraisal of papers Ian Tannock, CA | |
| 11:30 | Clinical case presentations and discussion | |
| 11:30 | A palliative care case Dirk Schrijvers, BE | |
| 11:50 | Case on infection Anastasia Constantinidou, CY | |
| 12:15 | Self assessment test | |
| 13:00 | Closing remarks | |
| 13:15 | Transfer to hotel or airport | |
Faculty
Matti Aapro, Clinique de Genolier, Genolier Cancer Center, Genolier, CH
Riccardo A. Audisio, Institute of Clinical Sciences - Sahlgrenska University Hospital, Dept. of Surgery, Göteborg, SE
Freddie Bray, International Agency for Research on Cancer, Cancer Surveillance Branch, FR
Silvia Brotea-Mosoiu, Oncology Institute of Bucharest, Medical Oncology Dept., Bucharest, RO
Anastasia Constantinidou, Bank of Cyprus Oncology Centre and Medical School University of Cyprus, Dept. of Oncology, Nicosia, CY
Lioe-fee De Geus-oei, Leiden University Medical Center, Nuclear Medicine and Molecular Imaging Department, Leiden, NL
Alexandru Eniu, Genolier Cancer Center, Clinique de Genolier, Medical Oncology Dpt., Genolier, CH
Joseph Gligorov, Institut Universitaire de Cancérologie AP-HP Sorbonne Uiversité, Oncologie Médicale site hôpital Tenon, Paris, FR
Douglas Hanahan, ISREC- Swiss Institute for Experimental Cancer, Dept. of Life Sciences, Lausanne, CH
Abdelkader Heddar, Luxembourg Institute of Health, LuxGen Genome Center, Dudelange, LU
Barbara Alicja Jereczek-Fossa, European Institute of Oncology, Dept. of Radiotherapy, Milano, IT
Danny Kupka, Freiburger Spital, HFR Kantonsspital Freiburg, Dept. of Oncology, Freiburg, CH
Carolin Mogler, Technical University Munich, Molecular Pathology Department, Munich, DE
Patrick Neven, University Hospitals Leuven, Gynaecologic Oncology, Leuven, BE
Stefan Rauh, Centre Hospitalier Emile Mayrisch Differdange et Esch, Medical Oncology/ Hematology Department, Esch-sur-Alzette, LU
Dirk Schrijvers, Ziekenhuisnetwerk Antwerpen-Middelheim, Dept. of Medical Oncology, Antwerp, BE
Matthias Schuppe, European Commission, Luxembourg, LU
Sophie Servais, University of Luxembourg, Oncology Department, Esch-sur-Alzette, LU
Petra Steyerova, General University Hospital Prague, Clinic of Radiology, Breast Cancer screening and diagnostic center, Prague 2, CZ
Ian Tannock, Princess Margaret Hospital, Department of Oncology and Hematology, Toronto, CA
Luzia Travado, Champalimaud Foundation, Champalimaud Clinical and Research Center, Lisbon, PT